These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 11209921)

  • 1. The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis.
    Muñoz SS; Li H; Ruberu K; Chu Q; Saghatelian A; Ooi L; Garner B
    J Biol Chem; 2018 Mar; 293(11):4071-4084. PubMed ID: 29414786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis.
    Persson T; Lattanzio F; Calvo-Garrido J; Rimondini R; Rubio-Rodrigo M; Sundström E; Maioli S; Sandebring-Matton A; Cedazo-Mínguez Á
    J Alzheimers Dis; 2017; 56(2):601-617. PubMed ID: 28035917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?
    Franco R; Cedazo-Minguez A
    Front Pharmacol; 2014; 5():146. PubMed ID: 25009496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the effect of the apolipoprotein E genotype on 4-year atrophy rates in an Alzheimer disease-related brain network.
    Hostage CA; Choudhury KR; Murali Doraiswamy P; Petrella JR;
    Radiology; 2014 Apr; 271(1):211-9. PubMed ID: 24475827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain.
    Gil-Bea F; Akterin S; Persson T; Mateos L; Sandebring A; Avila-Cariño J; Gutierrez-Rodriguez A; Sundström E; Holmgren A; Winblad B; Cedazo-Minguez A
    EMBO Mol Med; 2012 Oct; 4(10):1097-111. PubMed ID: 22933306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroautophagy-generated increase of lysosomal amyloid β-protein mediates oxidant-induced apoptosis of cultured neuroblastoma cells.
    Zheng L; Terman A; Hallbeck M; Dehvari N; Cowburn RF; Benedikz E; Kågedal K; Cedazo-Minguez A; Marcusson J
    Autophagy; 2011 Dec; 7(12):1528-45. PubMed ID: 22108004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.
    Cedazo-Mínguez A
    J Cell Mol Med; 2007; 11(6):1227-38. PubMed ID: 18205697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary.
    Juhász A; Rimanóczy A; Boda K; Vincze G; Szlávik G; Zana M; Bjelik A; Pákáski M; Bódi N; Palotás A; Janka Z; Kálmán J
    Neurochem Res; 2005 Aug; 30(8):943-8. PubMed ID: 16258842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer's disease.
    Crutcher KA
    J Mol Neurosci; 2004; 23(3):181-8. PubMed ID: 15181246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.
    Marques MA; Crutcher KA
    J Mol Neurosci; 2003; 20(3):327-37. PubMed ID: 14501016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E: a major piece in the Alzheimer's disease puzzle.
    Cedazo-Mínguez A; Cowburn RF
    J Cell Mol Med; 2001; 5(3):254-66. PubMed ID: 12067484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol attenuation of beta-amyloid-induced toxicity: a comparison o.
    Green PS; Perez EJ; Calloway T; Simpkins JW
    J Neurocytol; 2000; 29(5-6):419-23. PubMed ID: 11424958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells.
    Datki Z; Juhász A; Gálfi M; Soós K; Papp R; Zádori D; Penke B
    Brain Res Bull; 2003 Dec; 62(3):223-9. PubMed ID: 14698355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth.
    Bellosta S; Nathan BP; Orth M; Dong LM; Mahley RW; Pitas RE
    J Biol Chem; 1995 Nov; 270(45):27063-71. PubMed ID: 7592957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of apolipoprotein E on neurite outgrowth and beta-amyloid-induced toxicity in developing rat primary hippocampal cultures.
    Puttfarcken PS; Manelli AM; Falduto MT; Getz GS; LaDu MJ
    J Neurochem; 1997 Feb; 68(2):760-9. PubMed ID: 9003067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-VLDL protects against A beta(1-42) and apoE toxicity in human SH-SY5Y neuroblastoma cells.
    Cedazo-Mínguez A; Hüttinger M; Cowburn RF
    Neuroreport; 2001 Feb; 12(2):201-6. PubMed ID: 11209921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts.
    Cedazo-Mínguez A; Wiehager B; Winblad B; Hüttinger M; Cowburn RF
    Neurochem Int; 2001 Jun; 38(7):615-25. PubMed ID: 11290387
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.